PHARMASNPS INC.: CREATING AN ETHICS ADVISORY BOARD11This case study is of a real company that has been anonymized because the firm was acquired after the case was completed. The case study was written by Cécile M. Bensimon and David Finegold based on interviews they conducted on September 26, 2002 at Company headquarters. Four members of the company's EAB were also interviewed by phone. Unless otherwise specified, all quotes attributed to these people were obtained during interviews. This case study is one in a series produced under grants funded by The Seaver Institute and Genome Canada to study models for ensuring ethical decision making in bioscience firms. The participation, suggestions, and assistance of all involved are greatly appreciated.
1997 ◽
Vol 9
(1)
◽
pp. 115-122
Keyword(s):